PATENT CLAIM ANALYSIS

Application Number: 16336363
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "234200"]

Abstract:
The present invention relates to a class of cyano-substituted-heterocycles of Formula (I) with activity as inhibitors of deubiquitilating enzymes, in particular, ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30), having utility in a variety of therapeutic areas including cancer and conditions involving mitochondrial dysfunction. (I)

Claim (Index 12):
A compound according to  claim 11 , wherein:\n (i) X is C(R i )(R j ); R a  is selected from fluoro, C 1 -C 3  alkyl, and C 1 -C 3  alkoxy; and R i  and R j  are each independently selected from hydrogen and C 1 -C 3  alkyl; or (ii) X is O; and R a  is C 1 -C 3  alkyl.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 99.0
- Lexical Diversity: 1.32558
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16070936', '16080506', '15738900', '15894025', '16078518']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8443718480032933
- 35 USC 102 Novelty (BERT): 0.558174273734961
- Combined Prediction Score: 0.8157520905764601
- Mean Citation Score: 433.761262
- Max Citation Score: 448.00748
- Similarity Product: 341.1152915644503

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test